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Michael A Quail, Stephen D Bentley, Julian Parkhill†, Sharon J Peacock†
Summary
Background The emergence of meticillin-resistant Staphylococcus aureus (MRSA) that can persist in the community 
and replace existing hospital-adapted lineages of MRSA means that it is necessary to understand transmission 
dynamics in terms of hospitals and the community as one entity. We assessed the use of whole-genome sequencing 
to enhance detection of MRSA transmission between these settings.
Methods We studied a putative MRSA outbreak on a special care baby unit (SCBU) at a National Health Service 
Foundation Trust in Cambridge, UK. We used whole-genome sequencing to validate and expand ﬁ ndings from an 
infection-control team who assessed the outbreak through conventional analysis of epidemiological data and 
antibiogram proﬁ les. We sequenced isolates from all colonised patients in the SCBU, and sequenced MRSA isolates 
from patients in the hospital or community with the same antibiotic susceptibility proﬁ le as the outbreak strain. 
Findings The hospital infection-control team identiﬁ ed 12 infants colonised with MRSA in a 6 month period in 2011, 
who were suspected of being linked, but a persistent outbreak could not be conﬁ rmed with conventional methods. 
With whole-genome sequencing, we identiﬁ ed 26 related cases of MRSA carriage, and showed transmission occurred 
within the SCBU, between mothers on a postnatal ward, and in the community. The outbreak MRSA type was a new 
sequence type (ST) 2371, which is closely related to ST22, but contains genes encoding Panton-Valentine leucocidin. 
Whole-genome sequencing data were used to propose and conﬁ rm that MRSA carriage by a staﬀ  member had allowed 
the outbreak to persist during periods without known infection on the SCBU and after a deep clean. 
Interpretation Whole-genome sequencing holds great promise for rapid, accurate, and comprehensive identiﬁ cation 
of bacterial transmission pathways in hospital and community settings, with concomitant reductions in infections, 
morbidity, and costs.
Funding UK Clinical Research Collaboration Translational Infection Research Initiative, Wellcome Trust, Health 
Protection Agency, and the National Institute for Health Research Cambridge Biomedical Research Centre.
Introduction
Successful prevention of health-care-associated 
meticillin-resistant Staphylococcus aureus (MRSA) 
depends on eﬀ ective programmes of infection control, 
including detection of transmission events and outbreaks 
and eﬀ ective strategies for their containment and 
prevention.1,2 Until recently, the predominant focus of 
control eﬀ orts took place in health-care facilities, where 
most MRSA infections were caused by a small number 
of health-care-associated MRSA lineages that were poorly 
adapted for persistence in the community.3,4 This 
situation has undergone a fundamental shift, with the 
emergence of lineages of community-associated MRSA 
such as USA300 in the USA that can be carried for long 
periods by healthy people.5–7 Furthermore, community-
associated MRSA is now displacing previously dominant 
health-care-associated MRSA lineages,8 a process that is 
driven at least in part by repeated admission and 
discharge of some groups of patients. One implication of 
the blurring between health-care-associated and 
community-associated MRSA is that for the purpose of 
understanding the transmission dynamics of MRSA, 
hospitals and the community should no longer be 
regarded as separate entities. This distinction is 
problematic, because eﬀ ective linkage between the two 
settings is challenging for present strategies used for 
hospital-based infection control. 
One approach to tracking of MRSA transmission 
pathways between health-care facilities and the 
community could be to obtain and genotype MRSA 
isolates, and draw inferences on transmission on the 
basis of their genetic relatedness. Present typing methods 
are not ﬁ t for purpose because they are not suﬃ  ciently 
discriminatory, but this obstacle is set to change with the 
introduction of whole-genome sequencing.9,10 This 
technique provides the best discrimination between 
closely related bacterial isolates, and the rapidly 
decreasing cost and turnaround time of the technology 
means that it could become viable in diagnostic 
laboratories in the near future. Whole-genome 
sequencing has suﬃ  cient discriminatory power to 
reconstruct intercontinental and local transmission of 
MRSA lineages.9 Furthermore, bench-top, rapid 
turnaround whole-genome sequencing was able to 
distinguish between MRSA isolates that were associated 
with a putative outbreak in a neonatal intensive care unit 
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from those that were not associated with the outbreak.10 
We proposed that whole-genome sequencing could also 
be applied to show MRSA transmission between 
hospitals and the community, and thus emphasise where 
control strategies could be applied to prevent this 
occurrence.
We describe the investigation of a new, seemingly 
restricted MRSA outbreak in our special care baby unit 
(SCBU), in which a targeted MRSA sequencing strategy 
was used to detect a previously unsuspected extension of 
the outbreak into the community and subsequent 
movement of aﬀ ected individuals throughout the health-
care system. We compared detection of MRSA cases 
using conventional infection-control methods with 
targeted whole-genome sequencing in addition to 
conventional information sources. 
Methods
Study design and patients
Cambridge University Hospitals NHS Foundation Trust 
(CUH; Cambridge, UK) is a secondary and tertiary 
referral hospital with 1000 beds and 67 000 total inpatient 
admissions, 458 000 visits to outpatients, 115 000 day 
cases, and 93 000 emergency department attendances 
every year. The Rosie Hospital is the mother and baby 
hospital of the Trust, manages about 6000 deliveries 
every year, and contains a 24 cot SCBU that provides care 
for infants with acute and chronic neonatal medical and 
surgical conditions. All infants admitted to this unit are 
screened for MRSA carriage on admission and once per 
week thereafter. The onsite clinical microbiology and 
public health laboratory provides diagnostic microbiology 
services to the CUH, two additional National Health 
Service Trusts, and three primary care trusts in the area. 
About 800 000 clinical specimens are processed every 
year, 30% of which originate from primary care. In 2011, 
the laboratory identiﬁ ed nearly 3000 samples as MRSA 
positive from about 1500 individuals, with more than a 
third of these samples coming from primary care or 
outpatient settings. Infection-control management 
structures, standards, policies, and procedures 
supporting the prevention and control of infection at 
CUH are described in our annual report.11 Ethical 
approval was not required for the study because it was 
done as part of surveillance and management of health-
care-associated infection. Research and development 
approval for whole-genome sequencing was granted by 
the research and development department at CUH. 
Procedures
We cultured MRSA from screening swabs and clinical 
specimens by plating on to MRSA selective medium 
(Brilliance MRSA chromogenic medium, Oxoid, 
Basingstoke, UK). We identiﬁ ed bacteria with a 
commercial latex agglutination kit (Pastorex Staph Plus, 
Bio Rad Laboratories, Hemel Hempstead, UK). We did 
antimicrobial susceptibility testing with disk diﬀ usion12 
for the following drugs: cefoxitin, ciproﬂ oxacin, 
erythromycin, fusidic acid, gentamicin, mupirocin, 
neomycin, rifampicin, tetracycline, and vancomycin. All 
isolates were assigned unique strain identiﬁ cation 
numbers. We prepared sequencing libraries from 500 ng 
of DNA extracted from each MRSA isolate as previously 
described,13 with ampliﬁ cation using Kapa Hiﬁ 
polymerase (Kapa Biosystems, Woburn, MA, USA). 
Whole-genome sequencing was done with an Illumina 
MiSeq (Illumina, San Diego, CA, USA) to generate 150 bp 
paired end reads, and interpreted by an investigator 
(SRH) who was masked to all clinical, epidemiological, 
and microbiological information. The genome data has 
been deposited in the European Nucleotide Archive 
(appendix). We aligned sequence reads to the 
chromosome (accession number HE681097) and plasmid 
(CP002148) of a reference isolate (HO 5096 0412) to 
identify single-nucleotide polymorphisms (SNPs) and 
insertions or deletions. This reference isolate was deﬁ ned 
by multilocus sequence typing as sequence type (ST) 22. 
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication. 
Results
In 2011, we noted three contemporaneous cases of MRSA 
carriage on the SCBU at the CUH (patients 11–13; 
ﬁ gure A). We regarded these cases as a possible outbreak 
because of the temporal clustering of the cases and 
identical (patient 11 and patient 12) or near identical 
(patient 13) antibiotic susceptibility proﬁ les (appendix). 
The infection-control team did an investigation in which 
they completed a systematic review of MRSA isolates 
from the SCBU during the preceding 6 months. This 
review identiﬁ ed another 13 infants with one or more 
positive MRSA screens (patients 1–10 in ﬁ gure A, and a 
further three cases not shown). Comparison of the 
antibiograms (appendix) showed that isolates from eight 
of the 13 infants (patient 2, patients 4–10, ﬁ gure A) had an 
identical pattern to isolates from patient 11 and patient 12, 
whereas isolates from the ﬁ ve other cases diﬀ ered by at 
least two antibiotics and were therefore excluded by the 
infection control investigation from the suspected 
outbreak on the basis of usual practice in our hospital 
(patient 1, patient 3 and the three cases not shown). Thus, 
11 infants (patient 2 and patients 4–13) were regarded by 
the infection-control team to be putatively linked 
(ﬁ gure A). Mapping of these 11 cases to a timeline showed 
that they occurred in three discrete periods, interspersed 
with gaps of 17 days and 33 days, during which no carriers 
were detected (ﬁ gure A). These two gaps meant that the 
infection-control team was unable to conclude whether a 
putative outbreak had extended over the 6 months. The 
See Online for appendix
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recommended actions were to do a deep clean, reinforce 
infection-control policy and practice, and continue 
surveillance by weekly MRSA screens. Another infant 
(patient 14) was detected with carriage of MRSA 4 days 
after the deep clean was completed, which seemed linked 
to previous cases on the basis that the antibiogram was 
identical to patient 11 and patient 12. Overall, the infection-
control team assessed 17 cases of MRSA: three cases that 
triggered the investigation, 13 cases that occurred during 
the previous 6 months, and one case identiﬁ ed after the 
deep clean of the SCBU. 12 of these 17 cases were regarded 
as linked by infection control and ﬁ ve were discounted.
We showed previously that whole-genome sequencing 
could distinguish between MRSA isolates that are 
involved in an outbreak and those isolates that are not 
involved.10 Thus, we aimed to retrospectively assess the 
accuracy of the infection-control investigation of the 
SCBU outbreak with bacterial sequencing. We 
anonymised and sequenced the ﬁ rst MRSA isolate from 
all 17 infants on SCBU who were originally assessed by 
the infection-control investigation. We used sequencing 
data to assign each isolate to a sequence type, and noted 
that 14 isolates were a new sequence type, designated as 
ST2371 following submission to the multilocus sequence 
typing website, whereas three other isolates were ST1, 
ST8, or ST22 (also known as epidemic MRSA-15, which 
accounts for about 80% of health-care-associated MRSA 
infection in the UK). ST2371 is a single locus variant of 
ST22, and diﬀ ered by one point mutation based on 
multilocus sequence typing in arcC. ST2371 isolates also 
diﬀ ered from the ST22 reference in that they possessed 
the genes coding for Panton-Valentine leucocidin (PVL), 
Figure: Epidemiology and phylogeny of an outbreak of MRSA sequence type 2371 
(A) Epidemiological map of 14 infants on the SCBU (patients 1–14). (B) Phylogenetic tree based on whole-genome sequencing of MRSA isolates from patients 1–14. (C) Epidemiological map of 
patients 1–14 and ten other patients (patients 16, 17, and 19–26) with linked MRSA infection detected in the community; coloured lines link members of the same family. (D) Phylogenetic tree based 
on whole-genome sequencing of MRSA isolates from patients 1–14 and patients 16, 17, and 19–26. (E) Epidemiological map of all cases of MRSA identiﬁ ed by whole-genome sequencing, and one 
patient (patient 18) suspected of being linked to the outbreak but for whom no MRSA colonisation was detected. (F) Phylogenetic tree of all cases of MRSA in the outbreak; 20 individual MRSA 
colonies from a staﬀ  member are shown in red boxes, with multiple colonies from the staﬀ  member shown in parentheses. Boxes shown for infants on SCBU in panel A represent duration of hospital 
stay (black boxes show infants included by the infection-control investigation and white boxes show infants excluded by the infection-control team). Grey vertical blocks in A, C, and E show times on 
the SCBU when there were no known carriers of MRSA. MRSA=meticillin-resistant Staphylococcus aureus. SCBU=special care baby unit. SNP=single-nucleotide polymorphism. P=patient.*Out-group 
was the sequence type 22 reference genome. 
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which was not identiﬁ ed before sequencing. A 
phylogenetic tree based on core SNPs identiﬁ ed a 
unique, highly related cluster made up of all ST2371 
isolates (ﬁ gure B). Only 20 SNPs diﬀ erentiated these 
14 isolates from each other, compared with a mean of 
550 SNPs between ST2371 isolates and the reference 
ST22 genome. In view of the epidemiological data, we 
regarded this ﬁ nding as consistent with the involvement 
of 14 isolates in the SCBU outbreak. 
The infection-control team had correctly excluded three 
isolates (ST1, ST8, and ST22) from the outbreak, but had 
also incorrectly excluded two isolates (patient 1 and 
patient 3; ﬁ gure A) that belonged to the ST2371 clone. 
This decision had been made because these two isolates 
diﬀ ered from the outbreak antibiogram by two antibiotics 
(appendix). In retrospect, this diﬀ erence in susceptibility 
pattern proved to be incorrect because repeat 
antimicrobial susceptibility testing conﬁ rmed these two 
clones had the same proﬁ le as the outbreak. Additionally, 
whole-genome sequencing suggested that the outbreak 
spanned the MRSA-free periods on the SCBU.
The infection-control team were not aware of any 
MRSA transmission events outside of the SCBU, but we 
hypothesised that MRSA had extended beyond the 
boundary of the SCBU and used targeted MRSA 
sequencing to identify MRSA transmission and infection 
in their contacts. From the hospital microbiology 
laboratory information system, we identiﬁ ed all MRSA 
isolates cultured and stored since the start of the putative 
outbreak. We selected 15 MRSA isolates with an 
antibiogram that was no more than one antibiotic 
diﬀ erent from the original outbreak antibiogram (ie, 
patient 11 and patient 12). We also started prospective 
surveillance of the microbiology database after 
identiﬁ cation of patient 14, which yielded four other 
MRSA isolates with the outbreak antibiogram from non-
SCBU samples in the subsequent 3 months. Ten of these 
19 isolates were ST2371, ﬁ ve were ST22, and four were 
ST772. The ST2371 isolates were all closely related to the 
14 infant-associated ST2371 isolates from the SCBU 
(patients 1–14), with only 34 SNPs between all 24 isolates 
(ﬁ gure D). Thus, we suspected that the ten new cases 
might be linked to the SCBU through a previously 
undetected transmission network. 
We identiﬁ ed the source of sample submission for the 
ten ST2371 isolates as family doctors (six patients), the 
emergency department at CUH (two patients), and the 
breast surgery outpatient clinic at the CUH (two 
patients). We obtained clinical information from the 
hospital information system to determine whether 
epidemiological links could be made between these ten 
cases and the SCBU outbreak. At least one clear link 
could be made to the SCBU outbreak for nine people 
(excluding patient 24), with the resulting emergence of a 
complex network of transmission pathways from infants 
to their mothers, from mothers-to-mothers in the 
postnatal ward, and to partners of aﬀ ected mothers 
(ﬁ gure C). Two infants (patient 16 and patient 17) 
presented to a primary care clinic or the emergency 
department with an abscess, and had been inpatients on 
SCBU during the outbreak period when they had been 
MRSA-screen negative. Two aﬀ ected mothers (patient 20 
and patient 21) did not have infants on SCBU, but did 
have contact with mothers of MRSA-positive infants on 
SCBU. One mother with a breast abscess (patient 24) did 
not seem to have a direct link to a known MRSA carrier, 
but did have an infant (patient 18) who was an inpatient 
on SCBU for 5 days (ﬁ gure E). Her infant had an initial 
single negative MRSA screen during admission, but we 
believe that covert MRSA colonisation occurred and was 
followed by transmission to the mother.
We further examined medical records to assess whether 
clinical infection was documented in the 24 cases from 
which MRSA ST2371 was isolated. 14 of these patients 
had documented clinical infection (table), four while in 
the SCBU. Five mothers had breast abscesses, one of 
which was associated with cellulitis and tissue necrosis. 
The predominance of skin and soft-tissue infections we 
noted is consistent with the ﬁ nding that ST2371 encodes 
PVL. All individuals were treated with MRSA 
decolonisation therapy and all ten patients with an 
abscess received systemic antibiotics.
Prospective longitudinal surveillance for MRSA 
carriage on the SCBU led us to identify a new MRSA 
carrier (patient 15) who was admitted 64 days after the 
previous MRSA-positive patient left the unit (ﬁ gure E). 
We sequenced this isolate immediately on the MiSeq 
platform, with a culture to sequence turnaround of 48 h,10 
and noted that the isolate was ST2371 with only four 
SNPs diﬀ erent from the genetically closest SCBU 
outbreak isolate (ﬁ gure F). We noted that there was only 
one SNP diﬀ erence between the MRSA isolates from 
patient 15 and patient 24, suggesting a possible 
transmission pathway (ﬁ gure E). The re-emergence of 
ST2371 on the SCBU after the deep clean led us to 
suspect that one or more members of staﬀ  might be 
carrying and transmitting the outbreak MRSA strain. 
This notion was supported by the structure of the 
phylogenetic tree for the SCBU outbreak isolates, which 
did not show a strong temporal signature of sequential 
patient transmission, but suggested that repeated 
introduction from an external source was possible. The 
combined whole-genome sequencing and epidemio-
logical data were presented at a meeting of the infection-
control team, senior clinicians, nurses, and managers on 
the SCBU, which resulted in the decision to screen staﬀ  
members. After obtaining written informed consent, the 
infection-control team screened 154 SCBU staﬀ  members 
for MRSA colonisation. One staﬀ  member was positive 
for MRSA, which was conﬁ rmed as ST2371 with whole-
genome sequencing. The staﬀ  member was relieved 
from clinical duties and reviewed by the occupational 
health department. The staﬀ  member had no skin lesions 
and underwent successful MRSA decolonisation.
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We postulated that if the staﬀ  member had been linked 
to the outbreak, we might discover a genetic record by 
sequencing numerous colonies from the staﬀ  member 
and matching these with isolates from the infants. 
20 MRSA colonies were isolated from the original swab 
taken from the staﬀ  member and sequenced. When 
included in a phylogenetic tree with the isolates from the 
infants, we noted a cloud of diversity for the 20 staﬀ 
colonies, including strains that were a close genetic match 
to isolates from infants before and after the most recent 
MRSA-free gap of 64 days. In particular, 18 colonies from 
the staﬀ  member clustered with patient 15, who was the 
last infant to be colonised with MRSA in the SCBU. The 
other two colonies clustered closer towards the root of the 
tree (ﬁ gure F). From the number of SNPs between the 
staﬀ  MRSA colonies and a previously calculated mutation 
rate for ST22 of about one SNP per 15 weeks (MTG Holden, 
Wellcome Trust Sanger Institute, Cambridge, UK, 
personal com munication), we calculated a mean estimate 
for the time that the staﬀ  member was colonised of 
23 days before the ﬁ rst MRSA positive infant (patient 1) 
was detected (ﬁ gure E), and a range of 251 days before to 
164 days after the ﬁ rst case. Further evidence for 
transmission by the staﬀ  member either side of the 
MRSA-free gap came from the observation that a genetic 
change had occurred in 18 of 20 colonies involving loss of 
a plasmid that carried ermC (encoding erythromycin 
resistance). This genetic and corresponding phenotypic 
change was also reported for two other isolates, from the 
last infant carrier, patient 15, and from patient 24, whose 
child (patient 18) was on SCBU at the same time as 
patient 15 (ﬁ gure F). 
Discussion
In our study, more precise identiﬁ cation of patients 
involved in an outbreak of MRSA was possible with 
whole-genome sequencing than with standard infection-
control techniques (panel). Moreover, use of bacterial 
whole-genome sequencing in real time was able to 
identify the potential source of an ongoing MRSA 
outbreak and directly inform infection-control 
interventions. A conservative estimate of the UK National 
Health Service health-care costs attributable to the 
outbreak in our hospital was in excess of £10 000. By 
comparison, the cost of rapid whole-genome sequencing 
of one MRSA isolate is £95 at present, including sample 
preparation, library quality control, and sequencing.
The outbreak we investigated was chosen because 
standard approaches had already obtained information 
against which we could compare whole-genome 
Description Type of infection Presentation Treatment
Patient 1 Infant (part of outbreak) Superﬁ cial pustules Inpatient MRSA decolonisation therapy
Patient 2 Infant (part of outbreak) Superﬁ cial pustules Inpatient MRSA decolonisation therapy
Patient 4 Infant (part of outbreak) Superﬁ cial pustules Inpatient MRSA decolonisation therapy
Patient 11 Infant (part of outbreak) Superﬁ cial pustules Inpatient MRSA decolonisation therapy
Patient 16 Infant on SCBU for 5 days during 
outbreak, negative MRSA screen
Abscess (chest 
wall)
13 days after discharge from 
SCBU
One ED visit, one hospital outpatient clinic visit, 
four primary care visits, MRSA decolonisation 
therapy
Patient 17 Infant, on SCBU for 3 days during 
outbreak, negative MRSA screen
Abscess (cheek ) 29 days after discharge from 
SCBU
One primary care visit, MRSA decolonisation 
therapy
Patient 19 Mother of patient 16 (a known 
MRSA carrier on SCBU)
Abscess (breast) 21 days after infant discharged 
from SCBU
Two breast surgery clinic visits, one ED visit, two 
primary care visits, MRSA decolonisation therapy
Patient 20 Mother of infant not on SCBU; contact 
in postnatal ward with mothers of 
MRSA positive infants in SCBU
Abscess (breast) 17 days after discharged home 
following delivery
Four breast surgery clinic visits, one ED visit, one 
primary care visit, 3 days of inpatient treatment, 
MRSA decolonisation therapy
Patient 21 Mother of infant not on SCBU; contact 
in postnatal ward with mothers of 
MRSA-positive infants in SCBU
Abscess (breast) 26 days after discharged home 
following delivery 
Four breast surgery clinic visits, one ED visit, one 
primary care visit, MRSA decolonisation therapy
Patient 22 Mother of infant patient 8 (known 
MRSA carrier on SCBU)
Abscess (thigh) 175 days after MRSA carriage 
detected in own infant
One primary care visit, MRSA decolonisation 
therapy
Patient 23 Mother of infant patient 14 (known 
MRSA carrier on SCBU)
Abscess (breast) 18 days after MRSA carriage 
detected in own infant 
One ED visit, one breast surgery clinic visit, MRSA 
decolonisation therapy
Patient 24 Mother of patient 18 (MRSA-screen 
negative infant on SCBU)
Abscess (breast) 11 days after own infant was 
discharged from SCBU
Four breast surgery clinic visits, MRSA 
decolonisation therapy
Patient 25 Partner of patient 22 and father of 
infant patient 8
Abscess (ear) 257 days after MRSA carriage 
detected in infant, and 82 days 
since partner presented with 
abscess on thigh
One primary care visit, one ED visit, three hospital 
outpatient clinic visits, 1 day of inpatient 
treatment, MRSA decolonisation therapy
Patient 26 Partner of patient 20 Abscess (thigh) 325 days after mother and infant 
discharged home after delivery
One primary care visit, MRSA decolonisation 
therapy
MRSA=meticillin-resistant Staphylococcus aureus. SCBU=special care baby unit. ED=emergency department. 
Table: Clinical infections and transmission of MRSA sequence type 2371
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sequencing, but it was otherwise unremarkable. Whole-
genome sequencing of isolates with the same 
antibiogram collected within a year after the putative 
start of the outbreak identiﬁ ed ten previously unlinked 
cases of MRSA skin and soft-tissue infections occurring 
outside of the inpatient setting. These cases 
corresponded with transmission events between infants 
and their parents, and onward transmission between 
mothers in a postnatal ward, and were associated with 
substantial human morbidity and health-care costs. 
Three factors might have hampered the ability of the 
routine infection-control processes to detect trans-
missions: ﬁ rst, clusters of MRSA carriers in the SCBU 
were separated by periods when no MRSA carriers were 
detected; second, some cases presented in primary care 
or outpatient settings; and third, a substantial delay 
existed between the initial outbreak investigation and 
presentation of some of the community cases. Our 
ﬁ ndings probably represent the minimum number 
involved in the outbreak. Access to the microbiology 
database increased our capture of possible cases, but 
MRSA transmission to other individuals who did not 
present with infection could have eluded detection. This 
possibility is supported by reports that several infants 
who developed MRSA infection after discharge from 
hospital were MRSA screen negative on their initial 
screen in the SCBU, but presumably acquired MRSA 
before going home. This notion is plausible because 
routine MRSA screens were done once per week.
We showed that the SCBU cases were linked despite 
the absence of an obvious ongoing transmission chain, 
and rapidly noted a new case of MRSA 64 days after the 
last MRSA-positive patient had left the unit. This 
sequence of events suggested reintroduction from a 
carrier, who was identiﬁ ed as one of the staﬀ  members. 
Such rapid identiﬁ cation provides a practical application 
of whole-genome sequencing in a clinically relevant 
timeframe, which is associated with an intervention that 
reduced the risk of further transmission, infection, and 
associated morbidity. 
Sequencing of several colonies from the staﬀ  member 
showed that they were carrying many variants of the 
outbreak strain, as would be expected after prolonged 
carriage. We did not generate the sequence of multiple 
isolates from other patients, but in most cases the 
amount of time that elapsed between the putative time of 
acquisition and the point of sampling would not have 
been long enough to generate substantial variation in 
view of the known rate of mutation in the S aureus 
genome. That colonies carried by the staﬀ  member were 
segregated into those that matched most closely to 
isolates from infants before the 64 day MRSA-free gap 
and those after the gap suggests strongly that this staﬀ  
member had reintroduced the strain to the SCBU after 
the deep clean. However, we cannot be certain that the 
same staﬀ  member was responsible for transmission 
across the earlier MRSA-free periods. 
Whole-genome sequencing also showed the unexpected 
identiﬁ cation of a novel clone of MRSA that is closely 
related to the predominant health-care-associated MRSA 
clone in the UK, epidemic MRSA-15. Unlike the pattern of 
MRSA infection in the USA associated with the emergence 
of USA300, in which community-associated infection 
predominates and is associated with skin and soft-tissue 
infection, epidemic MRSA-15 is mainly associated with 
health-care-associated transmission and is not associated 
with extensive community transmission or skin and soft-
tissue infections. The biological behaviour of the novel ST 
seems to diﬀ er from epidemic MRSA-15 and is comparable 
with USA300,5,15–17 with transmission between family 
members, prolonged carriage, and increased rates of skin 
and soft-tissue infections. 
Health-care-associated MRSA is not routinely 
genotyped in the UK because most cases belong to a 
single clone (ST22), and so individual isolate types 
cannot be distinguished. The use of multilocus sequence 
typing during the investigation described here would 
have shown that the outbreak was due to a new clone, but 
Panel: Research in context
Systematic review
We searched PubMed without language restriction up to 
Nov 6, 2012, with the search terms “whole-genome 
sequencing” AND “MRSA” AND “outbreak”. We identiﬁ ed two 
studies10,14 in which whole-genome sequencing was used to 
retrospectively sequence clinical isolates of meticillin-
resistant Staphylococcus aureus (MRSA). These studies 
conﬁ rmed that whole-genome sequencing clustered isolates 
associated with outbreaks,10,14 and that sequence data were 
concordant with antimicrobial susceptibility testing and 
could be used to create an inventory of toxin genes.10 We 
identiﬁ ed no reports on the assessment of whole-genome 
sequencing to detect MRSA transmission networks between 
hospitals and the community. This absence of data is notable 
because MRSA control needs to bridge the gap between the 
two settings, and eﬀ ective linkage between the hospital and 
community is challenging for current strategies used by 
infection control.
Interpretation
Addition of whole-genome sequencing to an infection-control 
investigation of an MRSA outbreak in a special care baby unit 
allowed enhanced case detection and identiﬁ cation of an MRSA 
transmission network in our study, which extended into the 
community. Routine real-time use of whole-genome 
sequencing could have detected the outbreak 6 months earlier 
than identiﬁ cation based on clustering of cases, and might 
have prevented morbidity and costs resulting from MRSA 
transmission and subsequent infection. Development of 
techniques that provide automated analysis of sequence data 
and cost-beneﬁ t analyses of the use of this technology in the 
control of MRSA are needed.
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a shared multilocus sequence type alone would not have 
been deﬁ nitive proof that the sequenced isolates were all 
from one outbreak. Moreover, further testing would have 
been needed to show the presence of the gene coding for 
PVL. The time taken to detect this gene and perform 
multilocus sequence typing, including repeat sequencing 
to verify a new point mutation in arcC, would outweigh 
the time taken to do one sequencing run. In this study, 
isolates from patient 15 and patients 23–26 inclusive 
were prospectively sequenced with a sequencing run that 
took 1 day to complete and a bioinformatics pipeline that 
required less than 1 h of analysis time.
Whole-genome sequencing of MRSA could make an 
important contribution to infection-control investigation 
and practice. Rapid sequencing would have conﬁ rmed 
the outbreak on SCBU close to its start point, and routine 
whole-genome sequencing of MRSA from all new cases 
identiﬁ ed in the microbiology laboratory would have 
rapidly drawn links between the SCBU and the 
community. Implementation of routine whole-genome 
sequencing for MRSA would need the development of a 
central database for comparison of sequence data with 
previous local, national, and global isolates, and 
development of a system for automated interpretation 
and linking of genome sequence data. Nevertheless, 
such an approach holds great promise for rapid, accurate, 
and comprehensive identiﬁ cation of bacterial 
transmission pathways in hospital and community 
settings, with concomitant reductions in infections, 
morbidity, and costs.
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